Edwards Lifesciences Profit Margin Over Time
| EW Stock | USD 86.45 0.79 0.91% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Edwards Lifesciences Performance and Edwards Lifesciences Correlation. Edwards |
Is Edwards Lifesciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Edwards Lifesciences. If investors know Edwards will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Edwards Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.06) | Earnings Share 2.3 | Revenue Per Share 9.897 | Quarterly Revenue Growth 0.138 | Return On Assets 0.1225 |
The market value of Edwards Lifesciences Corp is measured differently than its book value, which is the value of Edwards that is recorded on the company's balance sheet. Investors also form their own opinion of Edwards Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Edwards Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Edwards Lifesciences' market value can be influenced by many factors that don't directly affect Edwards Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Edwards Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Edwards Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Edwards Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Net Profit Margin Analysis
Compare Edwards Lifesciences Corp and related stocks such as Medtronic PLC, Abbott Laboratories, and Boston Scientific Corp Profit Margin Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MDT | 0.132 | 0.132 | 0.132 | 0.132 | 0.132 | 0.1656 | 0.1656 | 0.1656 | 0.1656 | 0.1656 | 0.1203 | 0.1203 | 0.1203 | 0.1197 | 0.14 |
| ABT | 0.1385 | 0.1217 | 0.1495 | 0.1179 | 0.1128 | 0.2168 | 0.0671 | 0.0174 | 0.0774 | 0.1156 | 0.1299 | 0.1642 | 0.1588 | 0.1427 | 0.15 |
| BSX | 0.1817 | 0.0579 | (0.5612) | (0.0169) | 0.0362 | (0.032) | 0.0414 | 0.0115 | 0.1701 | 0.4378 | (0.0141) | 0.0876 | 0.055 | 0.1119 | 0.12 |
| ZBH | 0.1684 | 0.1709 | 0.1688 | 0.1646 | 0.1541 | 0.0083 | 0.0394 | 0.2351 | (0.0478) | 0.1418 | (0.0196) | 0.0588 | 0.0333 | 0.1385 | 0.15 |
| SYK | 0.0827 | 0.1619 | 0.1499 | 0.1115 | 0.0532 | 0.1447 | 0.1454 | 0.082 | 0.2612 | 0.1399 | 0.1114 | 0.1166 | 0.1278 | 0.1544 | 0.096 |
| DXCM | (21.4764) | (0.5867) | (0.5455) | (0.1862) | (0.0864) | (0.1433) | (0.1144) | (0.0699) | (0.1232) | 0.0685 | 0.2562 | 0.0632 | 0.1173 | 0.1495 | 0.16 |
| PODD | (433) | (0.3755) | (0.2454) | (0.182) | (0.1784) | (0.2786) | (0.0787) | (0.0579) | 0.0058 | 0.0157 | 0.0075 | 0.0153 | 0.0035 | 0.1216 | 0.13 |
| TNDM | (13.3411) | (13.3411) | (13.3411) | (2.1767) | (1.5994) | (0.9941) | (0.9905) | (0.6787) | (0.6668) | (0.0683) | (0.0689) | 0.0221 | (0.1181) | (0.2977) | (0.31) |
| ALGN | (37.5061) | 0.1391 | 0.1048 | 0.0974 | 0.1915 | 0.1703 | 0.1757 | 0.1571 | 0.2035 | 0.184 | 0.7184 | 0.1953 | 0.0968 | 0.1152 | 0.12 |
Edwards Lifesciences Corp and related stocks such as Medtronic PLC, Abbott Laboratories, and Boston Scientific Corp Net Profit Margin description
The percentage of revenue left after all expenses have been deducted from sales. The measure is calculated by dividing net profit by revenue.My Equities
My Current Equities and Potential Positions
| Edwards Lifesciences Corp | EW |
 | HealthcareFama & French Classification |
| Location | California; U.S.A |
| Exchange | New York Stock Exchange |
USD 86.45
Check out Edwards Lifesciences Performance and Edwards Lifesciences Correlation. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Complementary Tools for Edwards Stock analysis
When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |
Edwards Lifesciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.